For gastric cancer, adverse effects may include decreased hemoglobin, a decreased white blood cell count, a decreased neutrophil count, a decreased lymphocyte count, a decreased platelet count, nausea, a decreased appetite, increased aspartate aminotransferase, fatigue, increased blood alkaline phosphatase, increased alanine aminotransferase, diarrhea, hypokalemia, vomiting, constipation, increased blood bilirubin, pyrexia, and alopecia [110]. The gene discussed is GPT; the disease is Hypokalemia.